bioRxivBiochemistryPreprint
Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages
J. Steens, J. P. Bravo, C. R. P. Salazar, C. Yildiz, A. M. Amieiro, S. Kostlbacher, S. H. P. Prinsen, C. Patinios, A. Bardis, A. Barendrecht, R. A. Scheltema, T. J. G. Ettema, J. van der Oost, D. W. Taylor, R. Staals
Abstract
Type III CRISPR-Cas systems provide a sequence-specific adaptive immune response that protects prokaryotic hosts against viruses and other foreign genetic invaders. These crRNA-guided Cas effector complexes bind and cleave complementary RNA targets. Specific target binding stimulates the Cas10 subunit to generate cyclic oligoadenylate (cOA) signaling molecules, that in turn allosterically activate proteins carrying cognate sensory domains: CARF or SAVED. Here, we characterize an elaborate set of genes associated with the type III-B CRISPR-Cas system from Haliangium ochraceum, which includes a signal transduction module of a CBASS defense system with two caspase-like proteases, SAVED-CHAT and PCaspase (Prokaryotic Caspase). We show that binding of a 3-nucleotide cOA (cA3) to the SAVED domain of SAVED-CHAT induces its oligomerization into long filaments that activate the proteolytic activity of the CHAT domain. Surprisingly, we find that activated SAVED-CHAT specifically cleaves and activates the second protease, PCaspase. In turn, activated PCaspase cleaves a multitude of other proteins, including a putative sigma factor and a PCaspase-inhibitor. We expressed the type III-B system and its associated genes in E. coli and observed a strong abortive phenotype when offering a complementary target RNA, but only in the presence of both SAVED-CHAT and PCaspase. Together, our findings show an intriguing cascade of proteolytic activities (conceptually similar to eukaryotic caspases) in this bacterial immune system that reveals yet another strategy to effectively defend against mobile genetic elements.
- organism: bacteria (other)
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease
Sophie C. Binder, Niels Schneberger, … Gregor Hagelueken·Nucleic Acids ResearchPeer-reviewed·Jul 24, 2024
- Filament formation activates protease and ring nuclease activities of CRISPR SAVED-Lon
Dalia Smalakytė, Audronė Rukšėnaitė, … Gintautas Tamulaitis·Molecular CellPeer-reviewed·Oct 2, 2024
- A CARF-HAD phosphatase effector provides immunity during the type III-A CRISPR-Cas response
Gianna Stella, Linzhi Ye, … Luciano A. Marraffini·Nucleic Acids ResearchPeer-reviewed·Nov 26, 2025
- SAVED by a toxin: Structure and function of the CRISPR Lon protease.
C. Rouillon, N. Schneberger, … G. Hagelueken·bioRxiv·Dec 6, 2021
- Structural and functional insights into the type III-E CRISPR-Cas immunity
Xi Liu, Laixing Zhang, … Yue Feng·bioRxiv·Aug 22, 2022
- Type III CRISPR-Cas systems generate cyclic oligoadenylate second messengers to activate Csm6 RNases
O. Niewoehner, C. Garcia-Doval, … M. Jinek·bioRxiv·Jun 23, 2017